NO20040205L - Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoff - Google Patents
Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoffInfo
- Publication number
- NO20040205L NO20040205L NO20040205A NO20040205A NO20040205L NO 20040205 L NO20040205 L NO 20040205L NO 20040205 A NO20040205 A NO 20040205A NO 20040205 A NO20040205 A NO 20040205A NO 20040205 L NO20040205 L NO 20040205L
- Authority
- NO
- Norway
- Prior art keywords
- ion exchange
- active substance
- pharmaceutical preparations
- exchange resins
- preparations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134719A DE10134719A1 (de) | 2001-07-17 | 2001-07-17 | Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze |
| PCT/EP2002/007417 WO2003007995A2 (de) | 2001-07-17 | 2002-07-04 | Pharmazeutische zubereitungen enthaltend fluorochinolonbeladene ionentauscherharze |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20040205L true NO20040205L (no) | 2004-01-16 |
Family
ID=7692081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20040205A NO20040205L (no) | 2001-07-17 | 2004-01-16 | Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoff |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040247560A1 (https=) |
| EP (1) | EP1411894A2 (https=) |
| JP (1) | JP2005500332A (https=) |
| AR (1) | AR034777A1 (https=) |
| AU (1) | AU2002345086B2 (https=) |
| BR (1) | BR0211149A (https=) |
| CA (1) | CA2453616A1 (https=) |
| DE (1) | DE10134719A1 (https=) |
| MX (1) | MXPA04000332A (https=) |
| NO (1) | NO20040205L (https=) |
| NZ (1) | NZ530604A (https=) |
| WO (1) | WO2003007995A2 (https=) |
| ZA (1) | ZA200400269B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| EP2343089A4 (en) | 2008-09-23 | 2013-05-01 | Jaer S A Lab | USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION |
| DE102012021559A1 (de) | 2012-11-02 | 2014-05-08 | Technische Universität Bergakademie Freiberg | Verfahren zur Herstellung von submikronen makroporösen Ionenaustauschermaterialien durch mechansiche Zerkleinerung |
| US9669010B2 (en) | 2012-12-06 | 2017-06-06 | Bio Health Solutions, Llc | Treatment for chronic kidney disease |
| DK2928461T3 (da) * | 2012-12-06 | 2019-11-25 | Bio Health Solutions Llc | Behandling til kronisk nyresygdom |
| EP2808319A1 (en) * | 2013-05-31 | 2014-12-03 | Arevipharma GmbH | 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex |
| CA3098060A1 (en) | 2018-04-25 | 2019-10-31 | Bayer Animal Health Gmbh | Process for the hydrolysis of quinolone carboxylic esters |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA804914B (en) * | 1979-08-29 | 1981-08-26 | Rohm & Haas | The production of powdered resin and the powdered resin so produced |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
-
2001
- 2001-07-17 DE DE10134719A patent/DE10134719A1/de not_active Withdrawn
-
2002
- 2002-07-04 BR BR0211149-7A patent/BR0211149A/pt not_active IP Right Cessation
- 2002-07-04 NZ NZ530604A patent/NZ530604A/en unknown
- 2002-07-04 JP JP2003513600A patent/JP2005500332A/ja not_active Withdrawn
- 2002-07-04 US US10/483,635 patent/US20040247560A1/en not_active Abandoned
- 2002-07-04 AU AU2002345086A patent/AU2002345086B2/en not_active Ceased
- 2002-07-04 MX MXPA04000332A patent/MXPA04000332A/es not_active Application Discontinuation
- 2002-07-04 WO PCT/EP2002/007417 patent/WO2003007995A2/de not_active Ceased
- 2002-07-04 CA CA002453616A patent/CA2453616A1/en not_active Abandoned
- 2002-07-04 EP EP02743262A patent/EP1411894A2/de not_active Ceased
- 2002-07-12 AR ARP020102629A patent/AR034777A1/es not_active Application Discontinuation
-
2004
- 2004-01-14 ZA ZA2004/00269A patent/ZA200400269B/en unknown
- 2004-01-16 NO NO20040205A patent/NO20040205L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0211149A (pt) | 2004-06-29 |
| NZ530604A (en) | 2006-09-29 |
| CA2453616A1 (en) | 2003-01-30 |
| EP1411894A2 (de) | 2004-04-28 |
| ZA200400269B (en) | 2005-03-30 |
| AU2002345086B2 (en) | 2007-05-24 |
| US20040247560A1 (en) | 2004-12-09 |
| DE10134719A1 (de) | 2003-02-06 |
| WO2003007995A2 (de) | 2003-01-30 |
| WO2003007995A3 (de) | 2003-07-31 |
| JP2005500332A (ja) | 2005-01-06 |
| MXPA04000332A (es) | 2005-04-19 |
| AR034777A1 (es) | 2004-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1207867E (pt) | Formas de administracao farmaceuticas orais retardadas contendo tramadol | |
| DE69928085D1 (de) | Dosierungsform mit verlängerter wirkstoffabgabe | |
| DE50014244D1 (de) | Pharmazeutische tramadolsalze | |
| PT1439829E (pt) | Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa | |
| NO20010013D0 (no) | Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
| DK1204410T3 (da) | Farmaceutisk doseringsform med flere komponenter | |
| FIU20000164U0 (fi) | Uusi farmaseuttinen formulaatio | |
| NO20012915L (no) | Ny farmasöytisk formulering | |
| DK1100474T3 (da) | Todelt kapsel til optag af farmaceutiske tilberedninger til inhalatorer | |
| NO20032438D0 (no) | Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
| DE69918074D1 (de) | Makrolid-formulierung mit verzögerter wirkstoffabgabe | |
| NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
| FI991485A0 (fi) | Uusi farmaseuttinen koostumus | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| NO20042367L (no) | Mikronisert filmdannende pulver omfattende et aktivt stoff | |
| ID22878A (id) | Komposisi aktif secara terapi | |
| ATE279193T1 (de) | Pharmazeutische zubereitung von moxifloxacin | |
| NO20010277L (no) | Benzocykloheptener, fremgangsmÕte for fremstilling derav, farmasøytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter | |
| NO20014074D0 (no) | Farmasoytisk preparat inneholdende protonpumpeinhibitorer | |
| DE59915033D1 (de) | Pharmazeutische Zubereitung | |
| PL354028A1 (pl) | Farmaceutyczne roztwory levosimendanuFarmaceutyczne roztwory levosimendanu | |
| ATE257700T1 (de) | Pharmazeutische kombinationen mit tramadol | |
| DE59910298D1 (de) | Pharmazeutische levothyroxinzubereitung | |
| NO20040205L (no) | Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoff | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |